Abstract:Infection of high-risk human papillomaviruses (HPVs) is a prerequisite for the development of cervical carcinoma. HPV infections are also implicated in the development of other types of carcinomas. Chronic or persistent infection of HPV is essential but HPV alone is inadequate, additional endogenous or exogenous cues are needed along with HPV to induce cervical carcinogenesis. The strategies that high-risk HPVs have developed in differentiating epithelial cells to reach a DNA-synthesis competent state leading to tumorigenic transformation are basically due to overexpression of the E6 and E7 oncoproteins and the activation of diverse cellular regulatory or signaling pathways that are targeted by them. Moreover, the Wnt/β-catenin/Notch and phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathways are deregulated in various cancers, and have also been implicated in HPV-induced cancers. These are basically related to the "cancer hallmarks," and include sustaining proliferative signals, the evasion of growth suppression and immune destruction, replicative immortality, inflammation, invasion, metastasis and angiogenesis, as well as genome instability, resisting cell death, and deregulation of cellular energetics. These information could eventually aid in identifying or developing new diagnostic, prognostic biomarkers, and may contribute to design more effective targeted therapeutics and treatment strategies. Although surgery, chemotherapy and radiotherapy can cure more than 90% of women with early stage cervical cancer, the recurrent and metastatic disease remains a major cause of cancer mortality. Numerous efforts have been made to design new drugs and develop gene therapies to treat cervical cancer. In recent years, research on treatment strategies has proposed several options, including the role of HPV E5, E6, and E7 oncogenes, which are retained and overexpressed in most of the cervical cancers and whose respective oncoproteins are critical to the induction and maintenance of the malignant phenotype. Other efforts have been focused on antitumor immunotherapy strategies. It is known that during the development of cervical cancer, a cascade of abnormal events is induced, including disruption of cell cycle control, perturbation of antitumor immune response, alteration of gene expression, deregulation of microRNA and cancer stem cell and stemness related markers expression could serve as novel molecular targets for reliable diagnosis and treatment of HPV-positive cancers. However, the search for new proposals for disease control and prevention has brought new findings and approaches in the context of molecular biology indicating innovations and perspectives in the early detection and prevention of the disease. Thus, in this article, we discuss molecular signaling pathways activated by HPV and potential targets or biomarkers for early detection or prevention and the treatment of HPV-associated cancers.

Human Papillomaviruses and Cervical Neoplasia: A Model for Carcinogenesis

Human Papillomavirus: It’s Characteristics, Pathogenesis, Transmission, Immunity, and it’s Role in Cervical Cancer: A Mini Review

Human Papillomavirus and the Development of Different Cancers

Papillomaviruses and cancer: from basic studies to clinical application

Factors in the Formation of Neoplastic Processes in the Cervix

Human papillomavirus molecular biology and disease association

Role of the Common Fragile Sites in Cancers with a Human Papillomavirus Etiology

The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus

Molecular mechanisms of human papilloma virus related skin cancers: A review

Papel del virus del papiloma humano en el desarrollo del cáncer del cuello uterino.

[Research on the Oncogenesis of Cervical Epithelial Cells Co-Induced by Human Papillomavirus and Human Cytomegalovirus].

Comprehensive insights into human papillomavirus and cervical cancer: Pathophysiology, screening, and vaccination strategies

Human papillomavirus as a driver of head and neck cancers

Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses

Human Papillomavirus and Associated Cancers: A Review

HPV: Molecular pathways and targets

Refining our understanding of cervical neoplasia and its cellular origins

HPV-driven oncogenesis—much more than the E6 and E7 oncoproteins

Human Papillomavirus and Its Testing Assays, Cervical Cancer Screening, and Vaccination.

The ‘Why and How’ of Cervical Cancers and Genital HPV Infection

HPV Infections-Classification, Pathogenesis, and Potential New Therapies